{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:17:12Z","timestamp":1784809032116,"version":"3.55.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:00:00Z","timestamp":1366243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002174","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T21:01:45Z","timestamp":1366318905000},"page":"e2174","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis"],"prefix":"10.1371","volume":"7","author":[{"given":"Noushin","family":"Saljoughian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Zahedifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Doustdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Bolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaram","family":"Doroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiva","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Vasei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiollah","family":"Namvar Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"key":"ref1","first-page":"331","article-title":"Leishmaniasis","volume":"6","author":"ME Wilson","year":"1993","journal-title":"Curr Opin Infect Dis"},{"issue":"(1)","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","article-title":"Clinical spectrum of Leishmaniasis","volume":"22","author":"R Pearson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"BL Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1051\/parasite\/1990653111","article-title":"Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification","volume":"65","author":"JA Rioux","year":"1990","journal-title":"Ann Parasitol Hum Comp"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"P Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref7","first-page":"407","article-title":"Diagnosis & management of leishmania\/HIV co-infection","volume":"121","author":"PK Sinha","year":"2005","journal-title":"Indian J Med Res"},{"issue":"(57)","key":"ref8","first-page":"2","article-title":"Advances in battle against leishmaniasis","volume":"1998 Oct","year":"1998","journal-title":"TDR News"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"HW Murray","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89 Suppl 1","author":"F Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"E Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1566524043360203","article-title":"Leishmaniasis: current status of vaccine development","volume":"4","author":"B Sukumaran","year":"2004","journal-title":"Curr Mol Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"A Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"ref15","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"A Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of Vaccines against Visceral Leishmaniasis","volume":"2012","author":"KJ Evans","year":"2012","journal-title":"J Trop Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"RN Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.163.3.1467","article-title":"Protective immune responses induced by vaccination with an expression genomic library of Leishmania major","volume":"163","author":"D Piedrafita","year":"1999","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"I Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"RN Coler","year":"2007","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"L Gradoni","year":"2005","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"S Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"J Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Y Belkaid","year":"2002","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease","volume":"167","author":"JE Uzonna","year":"2001","journal-title":"J Immunol"},{"issue":"(Pt 2)","key":"ref26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/icb.1984.14","article-title":"Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection","volume":"62","author":"GF Mitchell","year":"1984","journal-title":"Aust J Exp Biol Med Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/374783","article-title":"Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines","volume":"187","author":"H Daneshvar","year":"2003","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0008-8749(85)90081-4","article-title":"Immunization of susceptible BALB\/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes","volume":"94","author":"RM Gorczynski","year":"1985","journal-title":"Cell Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/IAI.61.12.5205-5213.1993","article-title":"An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB\/c mice against infection with virulent L. major","volume":"61","author":"PB Kimsey","year":"1993","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"RG Titus","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"J Alexander","year":"1998","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1128\/MCB.17.10.5987","article-title":"Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite","volume":"17","author":"A Hubel","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"R Silvestre","year":"2007","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","article-title":"Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response","volume":"172","author":"JE Uzonna","year":"2004","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"B Papadopoulou","year":"2002","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","article-title":"Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages","volume":"16","author":"C Dumas","year":"1997","journal-title":"EMBO J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/nar\/gkr834","article-title":"Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species","volume":"40","author":"F Raymond","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"M Breton","year":"2005","journal-title":"Infect Immun"},{"key":"ref39","first-page":"244","article-title":"Lizard leishmania. Biology of the Kinetoplastida","author":"V Wilson","year":"1978","journal-title":"San Diego, CA: Academic Press"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/MCB.14.5.2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"H Charest","year":"1994","journal-title":"Mol Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1017\/S0031182009005873","article-title":"Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae","volume":"136","author":"H Azizi","year":"2009","journal-title":"Parasitology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"A Mizbani","year":"2009","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-6851(00)00377-7","article-title":"Identification of Leishmania major cysteine proteinases as targets of the immune response in humans","volume":"113","author":"S Rafati","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-4894(03)00097-3","article-title":"Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis","volume":"103","author":"S Rafati","year":"2003","journal-title":"Exp Parasitol"},{"key":"ref45","unstructured":"Coombs GH, Mottram JC (1997) Proteinases of trypanosomes and Leishmania: biology and control. London, UK: Oxford CAB International. pp. 177\u2013179."},{"key":"ref46","first-page":"99","article-title":"Parasite cysteine proteinases. Perspectives in Drug Discovery and Design","volume":"6","author":"CD Robertson","year":"1996","journal-title":"ESCOM Science Publisher"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-5793(89)81655-2","article-title":"A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension","volume":"258","author":"JC Mottram","year":"1989","journal-title":"FEBS Letters"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"16249","DOI":"10.1074\/jbc.274.23.16249","article-title":"Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif","volume":"274","author":"J Huete-Perez","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.exppara.2007.10.004","article-title":"Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB\/c mice","volume":"118","author":"S Rafati","year":"2008","journal-title":"Exp Parasitol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"S Rafati","year":"2005","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"S Rafati","year":"2006","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"S Rafati","year":"2001","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"A Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e1236","DOI":"10.1371\/journal.pntd.0001236","article-title":"C-terminal domain deletion enhances the protective activity of cpa\/cpb loaded solid lipid nanoparticles against Leishmania major in BALB\/c mice","volume":"5","author":"D Doroud","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2007.01.120","article-title":"Chemical adjuvants for plasmid DNA vaccines","volume":"25","author":"JR Greenland","year":"2007","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.18433\/J3R30T","article-title":"Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations","volume":"13","author":"D Doroud","year":"2010","journal-title":"J Pharm Pharm Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/j.1460-2075.1992.tb05444.x","article-title":"A novel antifolate resistance gene on the amplified H circle of Leishmania","volume":"11","author":"B Papadopoulou","year":"1992","journal-title":"EMBO J"},{"key":"ref58","unstructured":"Sambrook J, Fritsch E, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press."},{"key":"ref59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"D Doroud","year":"2011","journal-title":"J Control Release"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1383-5769(02)00039-9","article-title":"IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection","volume":"51","author":"A Viana da Costa","year":"2002","journal-title":"Parasitol Int"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"PA Buffet","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/JCM.40.1.210-215.2002","article-title":"Comparison of Six PCR Methods Using Peripheral Blood for Detection of Canine Visceral Leishmaniasis","volume":"40","author":"L Lachaud","year":"2002","journal-title":"Journal of Clinical Microbiology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"J Carrion","year":"2006","journal-title":"Parasite Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.micinf.2008.07.038","article-title":"Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?","volume":"10","author":"J Alexander","year":"2008","journal-title":"Microbes Infect"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijantimicag.2010.06.024","article-title":"Leishmaniasis vaccines: past, present and future","volume":"36 Suppl 1","author":"F Modabber","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"PM Kaye","year":"1991","journal-title":"J Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"J Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"ME Wilson","year":"2005","journal-title":"Microb Pathog"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imbio.2008.07.001","article-title":"Identification of regulatory T cells during experimental Leishmania infantum infection","volume":"214","author":"OR Rodrigues","year":"2009","journal-title":"Immunobiology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0169-4758(97)01060-0","article-title":"Leishmania vaccines: old and new","volume":"13","author":"E Handman","year":"1997","journal-title":"Parasitol Today"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1471-4922(01)02163-8","article-title":"Protective saliva: a novel approach to a Leishmania vaccine","volume":"17","author":"E Handman","year":"2001","journal-title":"Trends Parasitol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.166.3.1921","article-title":"Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms","volume":"166","author":"JA Streit","year":"2001","journal-title":"J Immunol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"WW Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"25703","DOI":"10.1074\/jbc.M402794200","article-title":"Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania","volume":"279","author":"A Selvapandiyan","year":"2004","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"S Nylen","year":"2007","journal-title":"J Exp Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1084\/jem.183.6.2559","article-title":"Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10","volume":"183","author":"F Gerosa","year":"1996","journal-title":"J Exp Med"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","article-title":"IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage","volume":"114","author":"A O'Garra","year":"2004","journal-title":"J Clin Invest"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/IAI.68.1.288-293.2000","article-title":"Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis","volume":"68","author":"HW Murray","year":"2000","journal-title":"Infect Immun"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"42","author":"JP Haldar","year":"1983","journal-title":"Infect Immun"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB\/c mouse versus syrian hamster model","volume":"42","author":"A Nieto","year":"2011","journal-title":"Veterinary Research"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"AC Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"639304","DOI":"10.1155\/2012\/639304","article-title":"Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani","volume":"2012","author":"R Bankoti","year":"2012","journal-title":"J Trop Med"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.exppara.2006.09.013","article-title":"Leishmania infantum: mixed T-helper-1\/T-helper-2 immune response in experimentally infected BALB\/c mice","volume":"115","author":"N Rolao","year":"2007","journal-title":"Exp Parasitol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.148.6.1858","article-title":"Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity","volume":"148","author":"HW Murray","year":"1992","journal-title":"J Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"S Stager","year":"2003","journal-title":"Infect Immun"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T05:32:33Z","timestamp":1688189553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002174"}},"subtitle":[],"editor":[{"given":"Eric","family":"Dumonteil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":85,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002174","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]}}}